(Q30393980)

21 June 2017

Nanotechnology and HIV: potential applications for treatment and prevention (English)

1 reference

21 June 2017

0 references

prevention of HIV/AIDS

0 references

author name string

Peter S Kim

series ordinal

1

1 reference

PubMed ID

20860050

21 June 2017

Sarah W Read

series ordinal

2

1 reference

21 June 2017

1 November 2010

1 reference

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

21 June 2017

1 reference

21 June 2017

2

1 reference

21 June 2017

6

1 reference

21 June 2017

693-702

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 June 2017

1 reference

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

21 January 2018

1 reference

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

21 January 2018

1 reference

21 January 2018

1 reference

HIV entry inhibitors and their potential in HIV therapy

21 January 2018

1 reference

21 January 2018

1 reference

Novel approaches to inhibiting HIV-1 replication.

21 January 2018

1 reference

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48.

21 January 2018

1 reference

Class-sparing regimens for initial treatment of HIV-1 infection

21 January 2018

1 reference

The challenge of finding a cure for HIV infection

21 January 2018

1 reference

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

21 January 2018

1 reference

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

21 January 2018

1 reference

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites

21 January 2018

1 reference

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS.

21 January 2018

1 reference

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs

21 January 2018

1 reference

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

21 January 2018

1 reference

Dendrimers as biopharmaceuticals: synthesis and properties

21 January 2018

1 reference

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

21 January 2018

1 reference

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].

21 January 2018

1 reference

Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques

21 January 2018

1 reference

Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro

21 January 2018

1 reference

Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer

21 January 2018

1 reference

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery

21 January 2018

1 reference

Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.

21 January 2018

1 reference

Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.

21 January 2018

1 reference

Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process

21 January 2018

1 reference

Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.

21 January 2018

1 reference

Nanochemistry-based immunotherapy for HIV-1.

21 January 2018

1 reference

Challenges in the development of an HIV-1 vaccine

21 January 2018

1 reference

Nanotechnology in vaccine delivery

21 January 2018

1 reference

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

21 January 2018

1 reference

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

21 January 2018

1 reference

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity

21 January 2018

1 reference

Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

21 January 2018

1 reference

Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.

21 January 2018

1 reference

Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques

21 January 2018

1 reference

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates

21 January 2018

1 reference

Mechanism of action of licensed vaccine adjuvants

21 January 2018

1 reference

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

21 January 2018

1 reference

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

21 January 2018

1 reference

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

21 January 2018

1 reference

Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers

21 January 2018

1 reference

Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen

21 January 2018

1 reference

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

21 January 2018

1 reference

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

21 January 2018

1 reference

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission

21 January 2018

1 reference

Microbicides for HIV prevention: reality or hope?

21 January 2018

1 reference

Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

21 January 2018

1 reference

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

21 January 2018

1 reference

Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

21 January 2018

1 reference

A randomized six-day safety study of an antiretroviral microbicide candidate UC781, a non-nucleoside reverse transcriptase inhibitor.

21 January 2018

1 reference

Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781

21 January 2018

1 reference

Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/WNAN.118

1 reference

21 June 2017

1 reference

PubMed ID

20860050